Warning: session_start(): open(/opt/alt/php74/var/lib/php/session/sess_820a37799f875beca98ad1d5fe71e307, O_RDWR) failed: Disk quota exceeded (122) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278

Warning: session_start(): Failed to read session data: files (path: /opt/alt/php74/var/lib/php/session) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278
Plus Products Files Preliminary Prospectus - Mushroomstocks | Mushroomstocks
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Plus Products Files Preliminary Prospectus

Aug 29, 2018 • 11:24 AM EDT
Cannabis (42).png
3 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Earlier this week, California-based Plus Products filed a preliminary prospectus, seeking to raise up to $15 Million. PI Financial and Canaccord Genuity are the lead underwriters for this offering and the company plans to list its shares on the Canadian Securities Exchange.

Plus Products will be conducting an initial public offering on the CSE and we are very excited by this opportunity. The edibles manufacturer and distributor has been executing flawlessly and has six infused edibles SKUs that are currently being sold in more than 200 licensed dispensaries and through delivery services such as Eaze.

2018 has been a major year for Plus Products and we recommend keeping an eye on this one. During the first half of the year, the company has generated $2.45 million in sales. In 2017, Plus generated $1.07 million in revenue and the growth has been very impressive.

Plus Products is well capitalized and well positioned to gain market share in California. In 2018, the company has raised more than $15 million and plans to use almost 40% of the capital raised to expand capacity.

A California Focused Cannabis Company

Plus Products has been using the capital to fund growth initiatives and to expand its reach. We are favorable on these growth initiatives and will monitor how the team continues to execute. The company is led by a strong management team that has a proven track record of success and this is a very important aspect of the story.

Plus is led by a management team that continues to execute and has the company positioned to capitalize on what will be a major opportunity. While many companies have expanded their focus to new markets, Plus remains laser focused on California and we think this is the right move.

While other markets are tempting, none are as big as California. Also, once Plus proves to be successful in California, the company can easily expand into new markets. When it comes to a strategic location, Plus is located in a market that is second-to-none and we think the company is positioned to capitalize on a cannabis boom in California.

Plus offers a product that is meant for users that are looking for a low dose and we find this to be very appealing. Plus’ gummy product has been rising in the ranks and according to BDS Analytics, is the fourth most popular edible in all of California.

An Attractively Valued Opportunity

The recent financing was completed at a valuation of approx. $25 million (pre-money) and we think the continued execution warrants a much higher valuation. When compared to a company like CannaRoyalty, which has a market cap that is above $300 million, Plus trades at 1.7x revenue. This is significant and leaves massive room for upside.

If you look at Nutritional High International Inc. (EAT.CN), which is much less developed when compared to Plus, the market cap is close to $100 million. Plus has a very attractive valuation and fundamentals continue to improve. This is an opportunity that cannot be ignored.

We think Plus represents one of the most exciting new opportunities and cannabis investors need to keep an eye on this one. The strong and improving fundamentals, leading management team and attractive valuation make this a company that cannot be missed.

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Mushroomstocks.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.

Fatal error: Uncaught ErrorException: md5_file(/home/useaicwl/public_html/wp-content/litespeed/css/e821d83a1954ddec62aaa9f035bf5368.css.tmp): failed to open stream: No such file or directory in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php:126 Stack trace: #0 [internal function]: litespeed_exception_handler(2, 'md5_file(/home/...', '/home/useaicwl/...', 126, Array) #1 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php(126): md5_file('/home/useaicwl/...') #2 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(797): LiteSpeed\Optimizer->serve('https://mushroo...', 'css', true, Array) #3 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(319): LiteSpeed\Optimize->_build_hash_url(Array) #4 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(252): LiteSpeed\Optimize->_optimize() #5 /home/useaicwl/public_html/wp-includes/class-wp-hook.php(310): LiteSpeed\Optimize->f in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php on line 126